Zebra Capital Management LLC Harvard Bioscience Inc Transaction History

Zebra Capital Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 17, 2021	SELL	$3.91 - $6.99 $48,225 - $86,214	-12,334 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$1.42 - $3.29 $3,210 - $7,438	-2,261 Reduced 15.49%	12,334 $27,000
Q4 2019 Feb 14, 2020	BUY	$2.45 - $3.25 $35,757 - $47,433	14,595 New	14,595 $45,000
Q2 2019 Aug 14, 2019	SELL	$1.93 - $4.59 $42,359 - $100,741	-21,948 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$2.77 - $4.38 $7,897 - $12,487	2,851 Added 14.93%	21,948 $95,000
Q4 2018 Feb 14, 2019	BUY	$3.03 - $5.0 $57,863 - $95,485	19,097 New	19,097 $61,000

30.6M

700

2.1K

Ticker HBIO
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 41,636,500
Market Cap $89.1M
Description
Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services that enables fundamental research, discovery, and pre-clinical testing for drug development in the United States and internationally. The company offers cellular and molecular technology instruments, such as syringe and peristaltic pump products, as w...

Get notified when there are updates to the investment portfolio of Zebra Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Zebra Capital Management LLC with notifications on news.